U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664657) titled 'To Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets in Healthy Participants Under Fasting Conditions' on June 18.
Brief Summary: An open-label, randomized, single dose study to assess dose proportionality and pharmacokinetic linearity in healthy participants under fasting condition.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Bioavailability and Pharmacokinetics
Intervention:
DIETARY_SUPPLEMENT: Vitamin C, Vitamin B2, Astragalus Root dry extract etc
This study to assess the pharmacokinetic profile of single ascending dose
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sic...